Skip to main content
SpringerLink
Log in

Off-label use common for some chemotherapeutic agents

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Conti RM, et al. Prevalence of Off-Label Use and Spending in 2010 Among Patent-Protected Chemotherapies in a Population-Based Cohort of Medical Oncologists. Journal of Clinical Oncology : 19 Feb 2013. Available from: URL: http://dx.doi.org/10.1200/JCO.2012.42.7252

    PubMed  Google Scholar 

  2. Off-Label Use of Cancer Drugs: A Benchmark Is Established. Journal of Clinical Oncology : 19 Feb 2013. Available from: URL: http://dx.doi.org/10.1200/JCO.2012.46.9460

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Off-label use common for some chemotherapeutic agents. PharmacoEcon Outcomes News 673, 7 (2013). https://doi.org/10.1007/s40274-013-0209-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0209-9

Search

Navigation